APA (7th ed.) Citation

Yaohua Cao, Lina Zhao, Tiantian Zhang, Tiantian Zhang, & Weiling Cao. (2021). Cost-Effectiveness Analysis of Adding Daratumumab to Bortezomib, Melphalan, and Prednisone for Untreated Multiple Myeloma. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yaohua Cao, Lina Zhao, Tiantian Zhang, Tiantian Zhang, and Weiling Cao. Cost-Effectiveness Analysis of Adding Daratumumab to Bortezomib, Melphalan, and Prednisone for Untreated Multiple Myeloma. Frontiers Media S.A., 2021.

MLA (9th ed.) Citation

Yaohua Cao, et al. Cost-Effectiveness Analysis of Adding Daratumumab to Bortezomib, Melphalan, and Prednisone for Untreated Multiple Myeloma. Frontiers Media S.A., 2021.